首页> 外文期刊>International journal of biological sciences >Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression
【24h】

Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression

机译:胰腺癌微环境中的中性粒细胞衍生蛋白酶-肿瘤进展中的活跃分子

获取原文
           

摘要

A hallmark of pancreatic ductal adenocarcinoma (PDAC) is the fibro-inflammatory microenvironment, consisting of activated pancreatic stellate cells, extracellular matrix proteins, and a variety of inflammatory cells, such as T cells, macrophages, or neutrophils. Tumor-infiltrating immune cells, which are found in nearly all cancers, including PDAC, often fail to eliminate the tumor, but conversely can promote its progression by altering the tumor microenvironment. Pancreatic cancer cells are able to attract polymorphonuclear neutrophils (PMN) via tumor secreted chemokines and in human PDAC, PMN infiltrates can be observed in the vicinity of tumor cells and in the desmoplastic tumor stroma, which correlate with undifferentiated tumor growth and poor prognosis. The behavior of tumor-infiltrating neutrophils in the tumor micromilieu is not yet understood at a mechanistic level. It has been shown that PMN have the potential to kill tumor cells, either directly or by antibody-dependent cell-mediated cytotoxicity, but on the other side various adverse effects of PMN, such as promotion of aggressive tumor growth with epithelial-to-mesenchymal transition and increased metastatic potential, have been described. Recent therapeutic approaches for PDAC focus not only the tumor cell itself, but also elements of the tumor microenvironment. Therefore, the role of PMN and their derived products (e.g. cytokines, proteases) as a new vein for a therapeutic target should be critically evaluated in this context. This review summarizes the current understanding of the interplay between proteases of tumor-infiltrating neutrophils and pancreatic tumor cells and elements of the desmoplastic stroma.
机译:胰腺导管腺癌(PDAC)的标志是纤维炎性微环境,由活化的胰腺星状细胞,细胞外基质蛋白和多种炎性细胞(例如T细胞,巨噬细胞或嗜中性白细胞)组成。在几乎所有癌症(包括PDAC)中都发现的肿瘤浸润免疫细胞通常无法消除肿瘤,但相反可以通过改变肿瘤微环境来促进其进展。胰腺癌细胞能够通过肿瘤分泌的趋化因子吸引多形核中性粒细胞(PMN),并且在人PDAC中,可以在肿瘤细胞附近和增生性肿瘤基质中观察到PMN浸润,这与未分化的肿瘤生长和不良预后相关。在机制水平上,尚不清楚肿瘤微环境中肿瘤浸润中性粒细胞的行为。已经显示出PMN具有直接或通过抗体依赖性细胞介导的细胞毒性杀死肿瘤细胞的潜力,但另一方面,PMN具有多种不良作用,例如通过上皮间质促进侵袭性肿瘤生长。已经描述了转移和增加的转移潜力。 PDAC的最新治疗方法不仅关注肿瘤细胞本身,而且关注肿瘤微环境的要素。因此,在这种情况下,应严格评估PMN及其衍生产品(例如细胞因子,蛋白酶)作为治疗目标的新途径的作用。这篇综述总结了目前对浸润肿瘤的中性粒细胞蛋白酶和胰腺肿瘤细胞之间的相互作用以及增生基质的组成部分的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号